{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:44Z","timestamp":1792823984474,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["PALM Project"],"award-info":[{"award-number":["PALM Project"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006694","name":"Associazione Italiana Contro le Leucemie - Linfomi e Mieloma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2020"],"award-info":[{"award-number":["PRIN 2020"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218866","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:41:27Z","timestamp":1791092487000},"page":"218866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reactive oxygen species define leukemia stem cell identity in pediatric acute myeloid leukemia"],"prefix":"10.1016","volume":"661","author":[{"given":"Maddalena","family":"Benetton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Da Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4143-8867","authenticated-orcid":false,"given":"Alberto","family":"Peloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Perpinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Frasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Branco Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Varotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Tregnago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Scorrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6996-0833","authenticated-orcid":false,"given":"Benjamin J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Meshinchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pigazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218866_bib1","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3324\/haematol.2022.281106","article-title":"Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023","volume":"108","author":"Egan","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2026.218866_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejca.2016.04.001","article-title":"Implementation of mechanism of action biology-driven early drug development for children with cancer","volume":"62","author":"Pearson","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218866_bib3","article-title":"Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013","volume":"2026","author":"Locatelli","year":"2026","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218866_bib4","article-title":"Navigating treatment options and communication in relapsed pediatric AML","volume":"44","author":"Graff","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. B"},{"key":"10.1016\/j.canlet.2026.218866_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2022.280800","article-title":"Leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"108","author":"Stelmach","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2026.218866_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103710","article-title":"Leukemic stem cells as a target for eliminating acute myeloid leukemia: gaps in translational research","volume":"175","author":"Khaldoyanidi","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2026.218866_bib7","series-title":"Leukemic Stem Cells: from Leukemic Niche Biology to Treatment Opportunities at","author":"Marchand","year":"2021"},{"key":"10.1016\/j.canlet.2026.218866_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218866_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.tips.2024.08.004","article-title":"Metabolic regulation in normal and leukemic stem cells","volume":"45","author":"Man","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2026.218866_bib10","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1182\/bloodadvances.2023009967","article-title":"Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity","volume":"7","author":"Rodriguez-Zabala","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218866_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-45691-4","article-title":"Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth","volume":"15","author":"Kellaway","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218866_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218866_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.867684","article-title":"Leukemia stem cell frequency at diagnosis correlates with measurable\/minimal residual disease and impacts survival in adult acute myeloid leukemia","volume":"12","author":"Kamel","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218866_bib14","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41375-018-0326-3","article-title":"CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia","volume":"33","author":"Zeijlemaker","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218866_bib15","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V86.10.3745.bloodjournal86103745","article-title":"A functional comparison of CD34+ CD38\u2013 cells in cord blood and bone marrow","volume":"86","author":"Hao","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","article-title":"Biology and relevance of human acute myeloid leukemia stem cells","volume":"129","author":"Thomas","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib17","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2015-11-683649","article-title":"GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo","volume":"127","author":"Pabst","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stems cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218866_bib19","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.canlet.2026.218866_bib20","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-204084","article-title":"Single cell multimodal framework identifies CD84 as a leukaemic stem cell target in paediatric AML","volume":"144","author":"Oporto Espuelas","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib21","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.ccell.2023.09.010","article-title":"Cooperative CAR targeting to selectively eliminate AML and minimize escape","volume":"41","author":"Haubner","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218866_bib22","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1182\/bloodadvances.2020001802","article-title":"CD200 expression marks leukemia stem cells in human AML","volume":"4","author":"Ho","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218866_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.canlet.2026.218866_bib24","first-page":"1","article-title":"Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia","volume":"131","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218866_bib25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218866_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218866_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid Leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218866_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-024-02510-5","article-title":"Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates","author":"Able","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218866_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1204895","article-title":"Therapeutic targeting of leukemia stem cells in acute myeloid leukemia","volume":"13","author":"Barbosa","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218866_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1200\/JCO.21.01595","article-title":"CD123 expression is associated with high-risk disease characteristics in childhood acute myeloid leukemia: a report from the children's oncology group","volume":"40","author":"Lamble","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218866_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-29668-9","article-title":"Allogeneic TCR\u03b1\u03b2 deficient CAR T-cells targeting CD123 in acute myeloid leukemia","volume":"13","author":"Sugita","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218866_bib32","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1182\/bloodadvances.2021004424","article-title":"Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia","volume":"5","author":"Kaeding","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218866_bib33","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-186012","article-title":"Dual-targeting CD33\/CD123 NANOBODY \u00ae T cell engager targeting leukemia blasts and stem\/progenitor cells in relapsed AML","volume":"142","author":"Zeng","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib34","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2016-10-696039","article-title":"Therapeutic targeting of acute myeloid leukemia stem cells","volume":"129","author":"Pollyea","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib35","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/bloodadvances.2025018002","article-title":"Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting","volume":"10","author":"Da Ros","year":"2026","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218866_bib36","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1182\/blood-2007-05-087759","article-title":"A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche","volume":"110","author":"Jang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218866_bib38","first-page":"557","article-title":"Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia","volume":"138","author":"Borella","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI130809","article-title":"A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia","volume":"130","author":"Williams","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218866_bib40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41375-017-0003-y","article-title":"Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML","volume":"32","author":"Zampini","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218866_bib41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218866_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tibs.2016.01.001","article-title":"Mitochondrial cristae: where beauty meets functionality","volume":"41","author":"Cogliati","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2026.218866_bib43","doi-asserted-by":"crossref","first-page":"R242","DOI":"10.1152\/ajpregu.00254.2022","article-title":"How does density of the inner mitochondrial membrane influence mitochondrial performance?","volume":"324","author":"Heine","year":"2023","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"10.1016\/j.canlet.2026.218866_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbabio.2019.06.015","article-title":"Mitochondrial cristae narrowing upon higher 2-oxoglutarate load","volume":"1860","author":"Dlaskov\u00e1","year":"2019","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.canlet.2026.218866_bib45","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-17-2282","article-title":"A phase I study of CPI-613 in combination with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia","volume":"24","author":"Pardee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218866_bib46","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1158\/1535-7163.MCT-18-0985","article-title":"Assessing metabolic intervention with a glutaminase inhibitor in real-time by hyperpolarized magnetic resonance in acute myeloid leukemia","volume":"18","author":"Zacharias","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2026.218866_bib47","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1158\/1535-7163.MCT-15-0163","article-title":"Antileukemic activity of 2-deoxy-D-glucose through inhibition of N-linked glycosylation in acute myeloid leukemia with FLT3-ITD or c-KIT mutations","volume":"14","author":"Larrue","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2026.218866_bib48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.celrep.2018.03.140","article-title":"PPM1K regulates hematopoiesis and leukemogenesis through CDC20-Mediated ubiquitination of MEIS1 and p21","volume":"23","author":"Liu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218866_bib49","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218866_bib50","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ccell.2023.10.008","article-title":"A longitudinal single-cell atlas of treatment response in pediatric AML","volume":"41","author":"Lambo","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218866_bib51","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","article-title":"Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia","volume":"37","author":"Granja","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218866_bib52","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood-2016-02-695312","article-title":"Evolution of acute myelogenous leukemia stem cell properties after treatment and progression","volume":"128","author":"Ho","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib53","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12320","article-title":"CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity","volume":"7","author":"Jacoby","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218866_bib55","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","article-title":"Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy","volume":"127","author":"Gardner","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218866_bib57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","article-title":"Hypoxia-Inducible factors: master regulators of cancer progression","volume":"2","author":"Schito","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218866_bib58","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.120076","article-title":"RhoB regulates cell migration through altered focal adhesion dynamics","volume":"2","author":"Vega","year":"2012","journal-title":"Open Biol."},{"key":"10.1016\/j.canlet.2026.218866_bib59","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3324\/haematol.2019.231944","article-title":"CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity","volume":"106","author":"Gutjahr","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2026.218866_bib60","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm909","article-title":"Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia","volume":"9","author":"Matsunaga","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218866_bib61","article-title":"CXCR4\/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218866_bib62","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218866_bib63","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218866_bib64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218866_bib65","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/14728222.2023.2261631","article-title":"OXPHOS-targeting drugs in oncology: new perspectives","volume":"27","author":"Kalyanaraman","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2026.218866_bib66","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.stem.2023.04.001","article-title":"Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia","volume":"30","author":"Beneyto-Calabuig","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218866_bib67","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41467-021-22625-y","article-title":"A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia","volume":"12","author":"Docking","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218866_bib68","author":"Sturgeon"},{"key":"10.1016\/j.canlet.2026.218866_bib69","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2013-03-491621","article-title":"Results of the AIEOP AML 2002\/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia","volume":"122","author":"Pession","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib70","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood-2012-09-454454","article-title":"Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group","volume":"120","author":"Pigazzi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib71","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1182\/blood-2012-11-469825","article-title":"CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype","volume":"121","author":"Masetti","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218866_bib72","series-title":"Core-Binding Factor Acute Myeloid Leukemia in Pediatric Patients Enrolled in the AIEOP AML 2002\/01 Trial: Screening and Prognostic Impact of c-KIT Mutations at Nature","author":"Manara","year":"2014"},{"key":"10.1016\/j.canlet.2026.218866_bib73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/leu.2016.177","article-title":"Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group","volume":"31","author":"Manara","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218866_bib74","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/leu.2016.361","article-title":"NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group","volume":"31","author":"Bisio","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218866_bib75","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2026.218866_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102107","article-title":"Evaluating mitochondrial length, volume, and cristae ultrastructure in rare mouse adult stem cell populations","volume":"4","author":"Triolo","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.canlet.2026.218866_bib77","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","article-title":"SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution","volume":"32","author":"Arg\u00fcello","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218866_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox's proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.canlet.2026.218866_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:24:58Z","timestamp":1792823098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":79,"alternative-id":["S0304383526006300"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218866","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactive oxygen species define leukemia stem cell identity in pediatric acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218866"}}